Personal information
Verified email domains
columbia.edu
natural killer cells, NK cells, natural killer cell development, immunology, cell biology, innate immunology
United States
Activities
Employment (2)
2024-02-14
to
present
Employment
Source:
Everardo Hegewisch-Solloa
2023-11-20
to
present
|
Postdoctoral Researcher
(Department of Pediatrics)
Employment
Source:
Everardo Hegewisch-Solloa
Education and qualifications (5)
2018-08-01
to
2023-11-15
|
PhD
(Cellular, Molecular, and Biomedical Studies)
Education
Source:
Everardo Hegewisch-Solloa
2018
to
2021
|
MPh.
(Integrated Program in Cellular, Molecular, and Biomedical Studies)
Education
Source:
Everardo Hegewisch-Solloa
2018
to
2020
|
M.A.
(Integrated Program in Cellular, Molecular, and Biomedical Studies)
Education
Source:
Everardo Hegewisch-Solloa
2017-09-15
to
2018-06-15
|
MSc
(Biological Sciences)
Education
Source:
Everardo Hegewisch-Solloa
2015-09-15
to
2017-06-17
|
BS Microbiology
(Biological Sciences)
Education
Source:
Everardo Hegewisch-Solloa
Professional activities (5)
2023-09
to
present
|
Herbert Irving Comprehensive Cancer Center Trainee Associate Member
Membership
Source:
Everardo Hegewisch-Solloa
2023-07
to
present
|
Columbia Stem Cell Initiative Work In-Progress committee member
Membership
Source:
Everardo Hegewisch-Solloa
2023-09
|
Travel Award
Distinction
Source:
Everardo Hegewisch-Solloa
2023-05-22
|
the Oberfield Prize in Pre-doctoral Science
(Department of Pediatrics)
Distinction
Source:
Everardo Hegewisch-Solloa
2022-05
|
Travel and Poster Award
Distinction
Source:
Everardo Hegewisch-Solloa
Funding (3)
2021-09-01
to
2024-08-31
|
Grant
National Institute of Allergy and Infectious Diseases
(Bethesda, US)
Source:
Everardo Hegewisch-Solloa
via
DimensionsWizard
2018-08
to
2019-08
|
Award
National Institute of Allergy and Infectious Diseases
(Md., Md., US)
GRANT_NUMBER:
T32-GM008224-32
Source:
Everardo Hegewisch-Solloa
Grant
National Institute of Allergy and Infectious Diseases
(Md., Md., US)
Part of
GRANT_NUMBER:
3R01AI137073 - 02W1
GRANT_NUMBER:
1R01AI137073
Source:
Everardo Hegewisch-Solloa
Works (13)
2024-10-11
|
Preprint
Contributors:
Hanane Touil;
Tain Luquez;
Natacha Comandante-Lou;
Annie J Lee;
Masashi Fujita;
Christian Habeck;
Alex Kroshilina;
Everardo Hegewisch-Solloa;
Julie McInvale;
Leah Zuroff
et al.
Source:
check_circle
Crossref
2023-09-25
|
Preprint
Contributors:
Seungmae Seo;
Sagar L. Patil;
Yong-Oon Ahn;
Jacqueline Armetta;
Everardo Hegewisch-Solloa;
Micah Castillo;
Nicole C. Guilz;
Achchhe Patel;
Barbara Corneo;
Malgorzata Borowiak
et al.
Source:
check_circle
Crossref
2023-09-06
|
Preprint
Contributors:
Everardo Hegewisch-Solloa;
Janine E. Melsen;
Hiranmayi Ravichandran;
André F. Rendeiro;
Aharon G. Freud;
Bethany Mundy-Bosse;
Johannes C. Melms;
Shira E. Eisman;
Benjamin Izar;
Eli Grunstein
et al.
Source:
check_circle
Crossref
Frontiers in Immunology
2023-08-18
|
Journal article
Contributors:
Leen Hermans;
Sofie Denaeghel;
Robert J. J. Jansens;
Steffi De Pelsmaeker;
Filip Van Nieuwerburgh;
Dieter Deforce;
Everardo Hegewisch-Solloa;
Emily M. Mace;
Eric Cox;
Bert Devriendt
et al.
Source:
Everardo Hegewisch-Solloa
Journal of Leukocyte Biology
2023-03-04
|
Journal article
Contributors:
Everardo Hegewisch-Solloa;
Ansel P Nalin;
Aharon G Freud;
Emily Mace
Source:
Everardo Hegewisch-Solloa
Cancer cell
2022-09-01
|
Journal article
Contributors:
Everardo Hegewisch-Solloa
Source:
Everardo Hegewisch-Solloa
Blood cancer discovery
2022-03-01
|
Journal article
Contributors:
Everardo Hegewisch-Solloa
Source:
Everardo Hegewisch-Solloa
Methods in molecular biology (Clifton, N.J.)
2022-01-01
|
Journal article
Contributors:
Everardo Hegewisch-Solloa
Source:
Everardo Hegewisch-Solloa
grade
Preferred source
(of
2)
The Journal of Immunology
2021-08-01
|
Journal article
Source:
Everardo Hegewisch-Solloa
Source:
Everardo Hegewisch-Solloa
Journal of leukocyte biology
2020-05-11
|
Journal article
Source:
Everardo Hegewisch-Solloa
Journal of clinical immunology
2020-04-01
|
Journal article
Source:
Everardo Hegewisch-Solloa
Blood advances
2020-04-01
|
Journal article
Source:
Everardo Hegewisch-Solloa